Peptides and Proteins
Peptides are short chains of amino acids linked by peptide bonds, whereas proteins are longer and more complex amino acid chains that can adopt functional three-dimensional structures. Both types of compounds are essential for various biological functions, such as catalysing reactions (enzymes), immune defence (antibodies), and cellular signalling. Proteins have a hierarchical structure, including the amino acid sequence, secondary, tertiary, and quaternary structures. Peptides are used in pharmaceutical and cosmetic therapies due to their specific biological properties, such as in the treatment of metabolic diseases or enhancing cellular regeneration. Proteins, on the other hand, have applications in biotechnology, nutrition, and regenerative medicine.
At CymitQuimica, we offer high-purity peptides and proteins for research in biotechnology and therapeutic applications.
Found 3128 products of "Peptides and Proteins"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid
CAS:Controlled Product<p>Applications (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid is an intermediate for Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C31H42N4O6Color and Shape:NeatMolecular weight:566.69(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride is an important co-factor of mammalian mitochondrial energy metabolism. It is also a good active ingredient for dry-skin.<br>References Geier, David A., et al.: Neurochem. Res., 38(11), 2336-2341 (2013);Tanno, Osamu, et al.: Fragrance J., 33(8), 82-85 (2005);<br></p>Formula:C7H16NO3·ClColor and Shape:White To Off-WhiteMolecular weight:197.6603,3',5,5'-Tetraiodo Thyroformic Acid (>90%)
CAS:<p>Impurity Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)<br>Applications 3,3',5,5'-Tetraiodo Thyroformic Acid (Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)) is a thyroid hormone analogue and a potent Thyroxine impurity.<br>References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),<br></p>Formula:C13H6I4O4Purity:>90%Color and Shape:White To Light BrownMolecular weight:733.80(±)-Methionine
CAS:<p>Applications (±)-Methionine is an essential amino acid involved in various biochemical processes in humans and mammals. Also in poultry meal as a source of nutrition.<br>References Martin-Venegas, R. et al.: Food Chem., 141, 1702 (2013); Austic, R. et al.: J. Agri. Food Chem., 61, 7341 (2013); Yan, L. et al.: J. Anim. Phys Anim Nutr., 97, 457 (2013);<br></p>Formula:C5H11NO2SColor and Shape:WhiteMolecular weight:149.21N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS:<p>Impurity Bortezomib USP Impurity B<br>Applications N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is a metabolite of Bortezomib (B675700), a proteasome inhibitor for the treatment of multiple myeloma and is known to also target the ubiquitin-proteasome pathway.<br>References Pekol, T., et al.: Drug. Meta. Disp., 33, 771 (2005); Hsieh, F.Y., et al.: J. Pharma. Biomed. Anal., 49, 115 (2009);<br></p>Formula:C14H14N4O2Color and Shape:NeatMolecular weight:270.29Tabimorelin
CAS:Controlled Product<p>Applications NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.<br>References Fabre, G., et al.: Biochem. Pharmacol., 37, 4389 (1988), Thummel, K., et al.: Clin. Pharmacol. Ther., 59, 491 (1996), Yu, D., et al.: J. Clin. Pharmacol., 39, 1203 (1999),<br></p>Formula:C32H40N4O3Color and Shape:NeatMolecular weight:528.68N,N-Dimethyl-4-hydroxymethoxy Clomiphene (~90%, contains ~10% Z-isomer)
CAS:Controlled ProductFormula:C25H26ClNO3Color and Shape:NeatMolecular weight:423.93Eptifibatide
CAS:Controlled Product<p>Applications An arginine-glycine-aspartate-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.<br>References Pathak, A., et al.: Cardiovas. Diabetol., 7 (2008), Hantgan, R., et al.: Biochem., 48, 8355 (2009), Giugliano, R., et al.: New Eng. J. Med., 360, 2176 (2009),<br></p>Formula:C35H49N11O9S2Color and Shape:Off White SolidMolecular weight:831.96N-Nitroso Lisinopril
CAS:Formula:C21H30N4O6Color and Shape:White To Light YellowMolecular weight:434.486Perfluorophenol
CAS:Controlled Product<p>Applications Perfluorophenol is used in the synthesis of PGA-films as biodegradable polymers. It also participates in the synthesis of tripod macrocyclic Gd(III) chelates for cancer molecular MRI.<br>References Lee, K. et al.: Langmuir., 20, 2531 (2004); Zhou, Z. et al.: Biomater., 34, 7683 (2013);<br></p>Formula:C6HF5OColor and Shape:NeatMolecular weight:184.06(R)-Hydroxy Des(boric Acid) Bortezomib
CAS:Controlled Product<p>Impurity Bortezomib USP Impurity I<br>Applications (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Formula:C19H24N4O3Color and Shape:NeatMolecular weight:356.42Carfilzomib (2R,4R)-Diol
Controlled Product<p>Applications Carfilzomib (2R,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C40H59N5O8Color and Shape:NeatMolecular weight:737.93Bortezomib
CAS:Controlled Product<p>Stability Hygroscopic and Moisture Sensitive<br>Applications Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Formula:C19H25BN4O4Color and Shape:White To Off-WhiteMolecular weight:384.24Carfilzomib
CAS:Controlled Product<p>Applications Carfilzomib is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Formula:C40H57N5O7Color and Shape:White To Off-WhiteMolecular weight:719.91Oxytocin-d5 Trifluoroacetate
CAS:Controlled Product<p>Applications Labelled Oxytocin. The principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.<br>References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),<br></p>Formula:C45H62D5F3N12O14S2Color and Shape:White To Off-WhiteMolecular weight:1126.24Voclosporin-d4
CAS:Controlled Product<p>Applications Labelled Voclosporin (V678500). A new agent for the treatment of noninfectious uveitis. Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile, a strong correlation between pharmacokinetic and pharmacodynamic response, and a wide therapeutic window. Immunosuppressant.<br>References Aspeslet, L., et al.: Transplant Proc., 33, 1048 (2001), Cho, M., et al.: Arthritis Rheum., 46, 1202 (2002), Staatz, C., et al.: Clin. Pharmacokinet., 43, 623 (2004),<br></p>Formula:C63H107D4N11O12Color and Shape:NeatMolecular weight:1218.65Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5)
CAS:Controlled Product<p>Applications Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) is an isotopically labelled form of Teduglutide (T013795), which is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.<br>References Jeppesen, P., et al.: Gut, 54, 1224 (2005)<br>Chemical Name: Jeppesen, P., et al.: Gut, 54, 1224 (2005)<br></p>Formula:C164H244D8N44O55S•C2HF3O2•x(H2O)Color and Shape:NeatMolecular weight:3760.081140218
![N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA622540.webp&w=3840&q=75)
